Study: Russia's Sputnik V vaccine appears safe, effective Researchers say based on their trial, which involved about 20,000 people in Russia last fall, the vaccine is about 91 per cent effective and that the shot also appeared to prevent people from becoming severely ill with COVID-19. The study was published online Tuesday in the journal, Lancet. Iran approves Russia's Sputnik V vaccine Iran, which is fighting the Middle East's deadliest outbreak, has said it will only rely on vaccines made by Russia, India or China, while also working to produce a homemade jab. Trials of Russian COVID-19 vaccine Sputnik V begin in UAE as cases rise The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 volunteers to be vaccinated at a hospital in the emirate of Abu Dhabi. Two doses of the vaccine will be given, 20 days apart, to volunteers, the statement said. Participants will have to be 18 years or older, have not previously been infected with COVID-19 or participated in other COVID-19 vaccine trials, it said. Russia says Sputnik V virus vaccine 95% effective The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. How Russia shortened the Covid vaccine race in rush to declare victory The vaccine will be ready for wide distribution late this year or early next, officials say. That's roughly the same schedule as shots from rivals in the U.S., U.K. and China. Initial results from final-stage studies won’t be ready until November, with full data expected next year. WHO in contact with russia on new coronavirus vaccine Sputnik V Russia has approved a coronavirus vaccine but the World Health Organisation is wary of it. "We are in close contact with Russian health authorities and discussions are ongoing with respect to possible WHO prequalification of the vaccine, but again prequalification of any vaccine includes the rigorous review and assessment of all required safety and efficacy data," WHO spokesman Tarik Jasarevic told.WHO in contact with russia on new coronavirus vaccine Sputnik V India among 20 countries interested in obtaining Covid-19 vaccine from Russia RDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Arabia, UAE, Brazil, India and Philippines, and start mass production in other countries in partnership with local sovereign wealth funds, including India, South Korea and Brazil, as well as, in Saudi Arabia, Turkey and Cuba, according to the statement. Russia announces World's 'first' Covid-19 vaccine, Putin says daughter inoculated Russia has developed the first vaccine offering "sustainable immunity" against the coronavirus, President Vladimir Putin announced Tuesday. "This morning, for the first time in the world, a vaccine against the new coronavirus was registered" in Russia, he said during a televised video conference call with government ministers. "One of my daughters had this vaccine. I think in this sense she took part in the experiment," Putin said.Russia announces World's 'first' Covid-19 vaccine, Putin says daughter inoculated Russia plans to register the world's first coronavirus vaccine on August 12 "The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trials are extremely important. We have to understand that the vaccine must be safe. Medical professionals and senior citizens will be the first to get vaccinated," Gridnev told reporters at the opening of a cancer centre building in the city of Ufa. UN: Discussions with Russia on experimental COVID-19 vaccine under way Last week, Russia became the first country in the world to license a coronavirus vaccine when President Vladimir Putin announced its approval. But the vaccine has not yet passed the advanced trials normally required to prove it works before being licensed, a major breach of scientific protocol. Russia aims to launch mass production of coronavirus vaccine doses by 2021 The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stages of development and is about to pass state registration, officials said. "We are very much counting on starting mass production in September," Industry Minister Denis Manturov said.